1 results
24/May/2022
DOI: 10.31744/einstein_journal/2022AO7001
ABSTRACT Objective: Low platelet reactivity levels are associated with higher risk of bleeding in patients receiving dual antiplatelet therapy relative to patients with optimal platelet blockade. This study set out to evaluate the prevalence of low platelet reactivity in patients with acute myocardial infarction treated with ticagrelor and aspirin. Methods: Patients admitted with acute myocardial infarction who were already undergoing dual antiplatelet therapy with aspirin and ticagrelor were enrolled. Blood samples were collected 1 hour before and 2 hours after […]
Keywords: Aspirin; Hemorrhage; Myocardial infarction; Platelet aggregation; Platelet aggregation inhibitors; Ticagrelor